SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042238
Filing Date
2019-11-08
Accepted
2019-11-08 16:02:02
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-10q_20190930.htm 10-Q 2940848
2 EX-31.1 mnkd-ex311_9.htm EX-31.1 9106
3 EX-31.2 mnkd-ex312_6.htm EX-31.2 9084
4 EX-32.1 mnkd-ex321_7.htm EX-32.1 7380
5 EX-32.2 mnkd-ex322_8.htm EX-32.2 7341
  Complete submission text file 0001564590-19-042238.txt   10191437

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnkd-20190930.xml EX-101.INS 2021514
7 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20190930.xsd EX-101.SCH 84077
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20190930_cal.xml EX-101.CAL 66643
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20190930_def.xml EX-101.DEF 362634
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20190930_lab.xml EX-101.LAB 575345
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20190930_pre.xml EX-101.PRE 499853
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 191204008
SIC: 2834 Pharmaceutical Preparations